Cargando…

Synthesis and cytotoxicity of the boron carrier pentagamaboronon-0-ol for boron neutron capture therapy against breast cancer

Boronic acid-containing curcumin analog, pentagamaboronon-0 (PGB-0), acts as a potential boron-carrier agent but has limited water solubility. Thus, a new compound (PGB-0-ol) with better chemical and pharmacological properties than PGB-0 has been synthesized. Molecular docking was performed using a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Utomo, Rohmad Yudi, Wulandari, Febri, Novitasari, Dhania, Susidarti, Ratna Asmah, Kirihata, Mitsunori, Hermawan, Adam, Meiyanto, Edy
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8820341/ https://www.ncbi.nlm.nih.gov/pubmed/35223445 http://dx.doi.org/10.4103/japtr.japtr_220_21

Ejemplares similares

Transcriptomics analyses reveal the effects of Pentagamaboronon-0-ol on PI3K/Akt and cell cycle of HER2+ breast cancer cells
por: Hermawan, Adam, et al.
Publicado: (2023)

Preparation of pentagamaboronon-0 and its fructose and sorbitol complexes as boron carrier for boron neutron capture therapy (BNCT) application
por: Susidarti, Ratna Asmah, et al.
Publicado: (2019)

The Evaluation of Cytotoxic Properties from CCB-2 Sugar Complexes Against TNBC and Non-TNBC Cells
por: Jenie, Riris Istighfari, et al.
Publicado: (2021)

Preparation and Cytotoxic Evaluation of PGV-1 Derivative, CCA-1.1, as a New Curcumin Analog with Improved-Physicochemical and Pharmacological Properties
por: Utomo, Rohmad Yudi, et al.
Publicado: (2022)

Synergistic Cytotoxic and Antimigratory Effect of Brazilein and Doxorubicin on HER2-Overexpressing Cells
por: Handayani, Sri, et al.
Publicado: (2022)

CCA-1.1, a Novel Curcumin Analog, Exerts Cytotoxic anti-Migratory Activity toward TNBC and HER2-Enriched Breast Cancer Cells
por: Novitasari, Dhania, et al.
Publicado: (2021)

Evaluation of the Potential of p‐Boronophenylalaninol as a Boron Carrier in Boron Neutron Capture Therapy, Referring to the Effect on Intratumor Quiescent Cells
por: Masunaga, Shin‐ichiro, et al.
Publicado: (2001)

Two Active Compounds from Caesalpinia sappan L. in Combination with Cisplatin Synergistically Induce Apoptosis and Cell Cycle Arrest on WiDr Cells
por: Handayani, Sri, et al.
Publicado: (2017)

Identification of potential targets of the curcumin analog CCA-1.1 for glioblastoma treatment : integrated computational analysis and in vitro study
por: Hermawan, Adam, et al.
Publicado: (2022)

The Anti-Proliferative Effect of Boron Neutron Capture Therapy in a Prostate Cancer Xenograft Model
por: Takahara, Kiyoshi, et al.
Publicado: (2015)

Antibody-Based Receptor Targeting Using an Fc-Binding Peptide-Dodecaborate Conjugate and Macropinocytosis Induction for Boron Neutron Capture Therapy
por: Nakase, Ikuhiko, et al.
Publicado: (2020)

Theranostics in Boron Neutron Capture Therapy
por: Sauerwein, Wolfgang A. G., et al.
Publicado: (2021)

Boron-peptide conjugates with angiopep-2 for boron neutron capture therapy
por: Xiang, Jing, et al.
Publicado: (2023)

Development and Elucidation of a Novel Fluorescent Boron-Sensor for the Analysis of Boronic Acid-Containing Compounds
por: Hattori, Yoshihide, et al.
Publicado: (2017)

Synthesis and Evaluation of Dodecaboranethiol Containing Kojic Acid (KA-BSH) as a Novel Agent for Boron Neutron Capture Therapy
por: Takeuchi, Koji, et al.
Publicado: (2020)

Boron microlocalization in oral mucosal tissue: implications for boron neutron capture therapy
por: Morris, G M, et al.
Publicado: (2000)

Nanostructured Boron Nitride With High Water Dispersibility For Boron Neutron Capture Therapy
por: Singh, Bikramjeet, et al.
Publicado: (2016)

Multi-Functional Boron-Delivery Agents for Boron Neutron Capture Therapy of Cancers
por: Oloo, Sebastian O., et al.
Publicado: (2023)

The Therapeutic Effects of Dodecaborate Containing Boronophenylalanine for Boron Neutron Capture Therapy in a Rat Brain Tumor Model
por: Fukuo, Yusuke, et al.
Publicado: (2020)

The Cytotoxic and Antimigratory Activity of Brazilin-Doxorubicin on MCF-7/HER2 Cells
por: Jenie, Riris Istighfari, et al.
Publicado: (2018)

Anomeric sugar boronic acid analogues as potential agents for boron neutron capture therapy
por: Imperio, Daniela, et al.
Publicado: (2019)

Boron rich nanotube drug carrier system is suited for boron neutron capture therapy
por: Heide, Fabian, et al.
Publicado: (2021)

A Novel Boron Lipid to Modify Liposomal Surfaces for Boron Neutron Capture Therapy
por: Shirakawa, Makoto, et al.
Publicado: (2021)

Chemoprevention curcumin analog 1.1 promotes metaphase arrest and enhances intracellular reactive oxygen species levels on TNBC MDA-MB-231 and HER2-positive HCC1954 cells
por: Novitasari, Dhania, et al.
Publicado: (2023)

The impact of TP53 status of tumor cells including the type and the concentration of administered (10)B delivery agents on compound biological effectiveness in boron neutron capture therapy
por: Masunaga, Shin-ichiro, et al.
Publicado: (2023)

Boron Neutron Capture Therapy for Malignant Brain Tumors
por: MIYATAKE, Shin-Ichi, et al.
Publicado: (2016)

Boron delivery agents for neutron capture therapy of cancer
por: Barth, Rolf F., et al.
Publicado: (2018)

Applicability of Combination with Tirapazamine in Boron Neutron Capture Therapy
por: Masunaga, Shin‐ichiro, et al.
Publicado: (1998)

Boron-neutron Capture on Activated Carbon for Hydrogen Storage
por: Romanos, Jimmy, et al.
Publicado: (2019)

Development of an Imaging Technique for Boron Neutron Capture Therapy
por: Fukumitsu, Nobuyoshi, et al.
Publicado: (2021)

Boron Neutron Capture Therapy: Current Status and Challenges
por: Wang, Song, et al.
Publicado: (2022)

Gold Nanoparticles as Boron Carriers for Boron Neutron Capture Therapy: Synthesis, Radiolabelling and In Vivo Evaluation
por: Pulagam, Krishna R., et al.
Publicado: (2019)

Remarkable Boron Delivery Of iRGD-Modified Polymeric Nanoparticles For Boron Neutron Capture Therapy
por: Chen, Jiejian, et al.
Publicado: (2019)

Polymer-Stabilized Elemental Boron Nanoparticles for Boron Neutron Capture Therapy: Initial Irradiation Experiments
por: Zaboronok, Alexander, et al.
Publicado: (2022)

A Boronated Derivative of Temozolomide Showing Enhanced Efficacy in Boron Neutron Capture Therapy of Glioblastoma
por: Xiang, Jing, et al.
Publicado: (2022)

Conference on Accelerator-based Neutron Sources for Boron Neutron Capture Therapy
Publicado: (1994)

Neutron Tube Design Study for Boron Neutron Capture Therapy Application
por: Verbeke, J M, et al.
Publicado: (1999)

Boron-Rich Boron Carbide Nanoparticles as a Carrier in Boron Neutron Capture Therapy: Their Influence on Tumor and Immune Phagocytic Cells
por: Kozień, Dawid, et al.
Publicado: (2021)

Analysis of boron neutron capture reaction sensitivity using Monte Carlo simulation and proposal of a new dosimetry index in boron neutron capture therapy
por: Takeno, Satoshi, et al.
Publicado: (2022)

A Boron Delivery Antibody (BDA) with Boronated Specific Residues: New Perspectives in Boron Neutron Capture Therapy from an In Silico Investigation
por: Rondina, Alessandro, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_2j6k2026amvi0bngr6sb12081m